MEI Pharma Inc.

NASDAQ: MEIP · Real-Time Price · USD
4.89
-0.01 (-0.20%)
At close: Aug 15, 2025, 3:59 PM
4.98
1.90%
After-hours: Aug 15, 2025, 07:55 PM EDT

MEI Pharma Balance Sheet Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
Cash & Equivalents
3.71M 16.91M 15.74M 8.54M
Short-Term Investments
34.64M 83.79M 137.51M 144.88M
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
n/a -13.28M -10.71M -9.28M
Receivables
n/a 85K 10.04M 7.58M
Inventory
n/a n/a n/a n/a
Other Current Assets
1.37M 6.75M 3.83M n/a
Total Current Assets
40.77M 107.53M 167.13M 164.82M
Property-Plant & Equipment
606K 13.28M 10.71M 9.28M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
606K 13.28M 10.71M 9.28M
Total Assets
41.38M 120.81M 177.84M 174.1M
Account Payables
3.17M 6.13M 7.92M 6.36M
Deferred Revenue
n/a 317K 4.83M 14.61M
Short-Term Debt
n/a 1.43M 871K 928K
Other Current Liabilities
2.82M 5.76M 5.6M 3.96M
Total Current Liabilities
8.36M 20.34M 24.44M 30.29M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a 1.6M 22.36M
Total Long-Term Liabilities
n/a 75.84M 100.98M 102.44M
Total Liabilities
8.36M 96.19M 125.43M 132.74M
Total Debt
n/a 12.73M 9.64M 8.3M
Common Stock
n/a n/a n/a n/a
Retained Earnings
-388.22M -406M -374.16M -327.81M
Comprehensive Income
n/a 0.00 n/a n/a
Shareholders Equity
33.02M 24.62M 52.41M 41.36M
Total Investments
34.64M 83.79M 137.51M 144.88M